GDRX Stock Recent News

GDRX LATEST HEADLINES

GDRX Stock News Image - MarketBeat

The GLP-1 weight loss trend continues to flourish, and the ante keeps rising. The reigning champions in the battle of the bulge are Novo Nordisk A/V NYSE: NVO with its Semaglutide medications Ozempic and Wegovy, and Eli Lilly & Co. NYSE: LLY with its Tirzepatide medications Mounjaro and Zepbound.

MarketBeat 2024 Apr 22
GDRX Stock News Image - Zacks Investment Research

Here is how GoodRx Holdings, Inc. (GDRX) and Amplifon S.p.A. (AMFPF) have performed compared to their sector so far this year.

Zacks Investment Research 2024 Apr 19
GDRX Stock News Image - Business Wire

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results before U.S. markets open on Thursday, May 9, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conferen.

Business Wire 2024 Apr 11
GDRX Stock News Image - Schaeffers Research

GoodRx Holdings Inc (NASDAQ:GDRX) stock is up 1.9% to trade at $6.87 this morning, after Keybanc upgraded the digital healthcare service to "overweight" from "sector weight," while setting a price target of $9.

Schaeffers Research 2024 Apr 10
GDRX Stock News Image - Zacks Investment Research

Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research 2024 Apr 09
GDRX Stock News Image - The Motley Fool

GoodRx got an upgrade from Wells Fargo. The analysts appreciate the company's increased-revenue visibility.

The Motley Fool 2024 Mar 25
GDRX Stock News Image - Zacks Investment Research

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research 2024 Mar 22
GDRX Stock News Image - Zacks Investment Research

The consensus price target hints at a 29.1% upside potential for GoodRx Holdings, Inc. (GDRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Investment Research 2024 Mar 15
GDRX Stock News Image - Zacks Investment Research

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks is more attractive to value investors?

Zacks Investment Research 2024 Mar 06
GDRX Stock News Image - Zacks Investment Research

GoodRx Holdings, Inc. (GDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research 2024 Mar 04
10 of 50